Sha Wang

Sha Wang is a Founding Partner at Terra Magnum Capital Partners, an investment firm managing $800 million focused on healthcare, education, and technology. In addition to this role, Sha serves on the Board of Advisors at New Markets Venture Partners and acts as a Board Observer for Lightcast and Arcellx, Inc. Membership on the Board of Directors at Berry Genomics, a major gene sequencing company listed on the Shenzhen Stock Exchange, further highlights Sha's expertise in the field. Sha also holds limited partner roles as an investor with several firms, including Perceptive Ventures, Owl Ventures, Vitalbridge Capital, Sherpa Capital, and Illumina Ventures. Educational qualifications include a PhD in Electrical Engineering from the University of Maryland and an EMBA in Finance from Tsinghua PBCSF.